 | Up a level |
Coleman, Rob, Brown, Janet, Rathbone, Emma, Flanagan, Louise, Reid, Amber, Kendall, Jessica, Howell, Sacha, Twelves, Chris, Palmieri, Carlo 
ORCID: 0000-0001-9496-2718, Anand, Anjana et al (show 2 more authors)
(2020)
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial.
TRIALS, 21 (1).
89-.
Coombes, R Charles, Howell, Sacha, Lord, Simon R, Kenny, Laura, Mansi, Janine, Mitri, Zahi, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Chap, Linnea I, Richards, Paul, Gradishar, William et al (show 13 more authors)
(2023)
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
NATURE COMMUNICATIONS, 14 (1).
4444-.
Palmieri, Carlo ORCID: 0000-0001-9496-2718, Stein, Rob C, Liu, Xinxue, Hudson, Emma, Nicholas, Hanna, Sasano, Hironobu, Guestini, Fouzia, Holcombe, Chris, Barrett, Sophie, Kenny, Laura et al (show 5 more authors)
(2017)
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
BREAST CANCER RESEARCH AND TREATMENT, 165 (2).
pp. 343-353.
Winter, Matthew, Coleman, Rob, Kendall, Jessica, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Twelves, Chris, Howell, Sacha, MacPherson, Iain, Wilson, Caroline, Purohit, Kash, Gath, Jacqui et al (show 6 more authors)
(2022)
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo<SUP>™</SUP>) in breast cancer patients with BONe metastases: CARBON trial results.
JOURNAL OF BONE ONCOLOGY, 35.
100442-.